1[1]Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate hpid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trial.JAMA,2004,291:1071-80.
2[4]Deng Z,Yang C,Deng H,et al.Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction.Int J Cardiol.2006,113:92-96.
3[5]Sazhina Eiu,Kozlova IV,Rebrow AP,et al.The degree of inflammation and endothelial dysfunction in treatment of chronic heart failure in patients with coronary artery disease Klin Med(Mosk).2006,84:20-24.
4Savonitto S,Ardissino D.Selection of drug therapy in stable angina pectoris.Cardiovasc Drugs Ther,1998,12(2):197～210.
5Kinlay S,Selwyn AP,Delagrange D,et al.Biological mechanisms for the clinical success of lipid-lowing in coronary artery disease and the use of surrogate end-points.Curr Opin Lipidol,1996,7(6):389～97.
6Lefer AM,Campbell B,Shin YK,et al.Simvastatin preserves the ischemic-reperfusion myocardium in normocholesterolemic rat hearts.Circulation,1999,100(2):178～84.
7Furchgott RF.The 1996 Albert Lasker Medical Research Awards.The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide.JAMA,1996,276(14):1186～1188.
8Weiland U,Haendeler J,Ihling C,et al.Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway.Cardiovas Res,2000,45(3):671～678.
9DeBer OJ,,VanderWal AC,Beeker AE.Atherosclerosis,inflammation,and infection[].Journal of Paleopathology.2000
10Shan K,Kurrelmeyer K,Seta Y,et al.The role of cytokines in disease progression in heart failure[].Current Opinion.1997
3Chiu JH,Abdelhadi RH,Chung MK,et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator[J]. Am J Cardiol, 2005,95 (4) : 490-491.
4Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the joint international and federation of cardiology World Health Organization task force on standardization of clinical nomenclature[J].Circulation,1979,(06):607-609.
5Feola M,Biggi A,Francini A. Placebo of trimetazidine (99m) Tc Tetrofosm in myocardial SPECT and low-dose dobutamine echocardiography in liberating myocardium[J].Archives of Medical Research,2006,(01):117-122.doi:10.1016/j.arcmed.2005.05.011.
